Welcome and Introductions (ID 4741)
Recurrence Post-Radical Resection: Are Systemic Therapies the Solution to Optimize Patient Outcomes? (ID 4742)
Biomarkers: Are We Ready to Use Them in Routine Clinical Practice? (ID 4743)
QoL: Is It a Key Endpoint in the Adjuvant Setting? (ID 4744)
Clinical Cases Discussion (Cisplatin-eligible case; Cisplatin-ineligible case) (ID 4745)
Closing Remarks (ID 4746)
Live Q&A session (ID 4747)